Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00938951 |
Recruitment Status
:
Completed
First Posted
: July 14, 2009
Last Update Posted
: February 9, 2012
|
Sponsor:
Alcon Research
Information provided by (Responsible Party):
Alcon Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dry Eye Symptoms Visual Performance | Other: Systane® Ultra | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 16 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | July 2009 |
Resource links provided by the National Library of Medicine

MedlinePlus related topics:
Eye Care
Drug Information available for:
Systane
U.S. FDA Resources
Arm | Intervention/treatment |
---|---|
Experimental: Systane® Ultra
Systane® Ultra
|
Other: Systane® Ultra
Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3%
|
Primary Outcome Measures
:
- Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session [ Time Frame: 60 minutes post-dosing with test article ]
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Player/ Coach must answer "Yes" to the survey eligibility question.
- Player/Coach must voluntarily agree to participate in survey
Exclusion Criteria:
No Contacts or Locations Provided
Responsible Party: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00938951 History of Changes |
Other Study ID Numbers: |
SMA-09-22 |
First Posted: | July 14, 2009 Key Record Dates |
Last Update Posted: | February 9, 2012 |
Last Verified: | February 2012 |
Keywords provided by Alcon Research:
Dry Eye Visual Performance |